These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3011165)

  • 21. [Anti-arrhythmic effect of phytoadaptogens].
    Maĭmeskulova LA; Maslov LN
    Eksp Klin Farmakol; 2000; 63(4):29-31. PubMed ID: 11022302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of peripheral delta opioid receptors increases cardiac tolerance to arrhythmogenic effect of ischemia/reperfusion.
    Maslov LN; Oeltgen PR; Lishmanov YB; Brown SA; Barzakh EI; Krylatov AV; Pei JM
    Acad Emerg Med; 2014 Jan; 21(1):31-9. PubMed ID: 24552522
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Opioid antagonist modulation of ischaemia-induced ventricular arrhythmias: a peripheral mechanism.
    Murphy DB; Murphy MB
    J Cardiovasc Pharmacol; 1999 Jan; 33(1):122-5. PubMed ID: 9890406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inability of an opioid antagonist lacking negative intrinsic activity to induce opioid receptor up-regulation in vivo.
    Morris BJ; Millan MJ
    Br J Pharmacol; 1991 Apr; 102(4):883-6. PubMed ID: 1649659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Central kappa- and mu-opiate receptors mediate ACTH-release in rats.
    Pfeiffer A; Herz A; Loriaux DL; Pfeiffer DG
    Endocrinology; 1985 Jun; 116(6):2688-90. PubMed ID: 2986960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological profile of various kappa-agonists at kappa-, mu- and delta-opioid receptors mediating presynaptic inhibition of neurotransmitter release in the rat brain.
    Mulder AH; Burger DM; Wardeh G; Hogenboom F; Frankhuyzen AL
    Br J Pharmacol; 1991 Feb; 102(2):518-22. PubMed ID: 1673074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The participation of the mu-, delta- and kappa-opioid receptors in the realization of the anti-arrhythmia effect of Rhodiola rosea].
    Maĭmeskulova LA; Maslov LN; Lishmanov IuB; Krasnov EA
    Eksp Klin Farmakol; 1997; 60(1):38-9. PubMed ID: 9162281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kappa-opioid peptide receptor stimulation increases cytosolic pH and myofilament responsiveness to Ca2+ in cardiac myocytes.
    Ventura C; Capogrossi MC; Spurgeon HA; Lakatta EG
    Am J Physiol; 1991 Nov; 261(5 Pt 2):H1671-4. PubMed ID: 1659231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Participation of central and peripheral mu- and delta opiate receptors in anti-arrhythmia action of enkephalins].
    Maslov LN; Lishmanov IuB
    Biull Eksp Biol Med; 1991 Aug; 112(8):124-6. PubMed ID: 1664748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo binding of benzomorphans to mu, delta and kappa opioid receptors: comparison with urine output in the rat.
    Richards ML; Sadée W
    J Pharmacol Exp Ther; 1985 May; 233(2):425-32. PubMed ID: 2987482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A steric theory of opioid agonists, antagonists, agonist-antagonists, and partial agonists.
    Martin WR
    NIDA Res Monogr; 1984 Mar; 49():16-23. PubMed ID: 6090916
    [No Abstract]   [Full Text] [Related]  

  • 32. Different motor actions of dynorphins and nonpeptide kappa opioid receptor agonists in the isolated rat colon.
    Scheurer U; Wenger F; Caliezi A; Drack E; Varga L; Halter F
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1324-30. PubMed ID: 1969475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of a kappa-opioid agonist on adrenocorticotropic and diuretic function in man.
    Pfeiffer A; Knepel W; Braun S; Meyer HD; Lohmann H; Brantl V
    Horm Metab Res; 1986 Dec; 18(12):842-8. PubMed ID: 3028922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Motor dysfunction after spinal cord injury is mediated by opiate receptors.
    Faden AI; Knoblach S; Mays C; Jacobs TP
    Peptides; 1985; 6 Suppl 1():15-7. PubMed ID: 2995941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Opioid kappa receptors and the secretion of prolactin (PRL) and growth hormone (GH) in the rat. II. GH and PRL release-inhibiting effects of the opioid kappa receptor agonists bremazocine and U-50,488.
    Krulich L; Koenig JI; Conway S; McCann SM; Mayfield MA
    Neuroendocrinology; 1986; 42(1):82-7. PubMed ID: 3001566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kappa agonist-induced diuresis: evidence for stereoselectivity, strain differences, independence of hydration variables and a result of decreased plasma vasopressin levels.
    Leander JD; Hart JC; Zerbe RL
    J Pharmacol Exp Ther; 1987 Jul; 242(1):33-9. PubMed ID: 3039112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-arrhythmic effect of kappa-opioid receptor stimulation in the perfused rat heart: involvement of a cAMP-dependent pathway.
    Yu XC; Wang HX; Pei JM; Wong TM
    J Mol Cell Cardiol; 1999 Oct; 31(10):1809-19. PubMed ID: 10525419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The opiatergic link between the antiarrhythmic effect of adaptation and hypoxia in the model of ischemia and reperfusion in vivo].
    Lishmanov IuB; Naryzhnaia NV; Maslov LN; Gross GJ
    Patol Fiziol Eksp Ter; 2003; (1):19-21. PubMed ID: 12652938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intrathecal morphine preconditioning induces cardioprotection via activation of delta, kappa, and mu opioid receptors in rats.
    Li R; Wong GT; Wong TM; Zhang Y; Xia Z; Irwin MG
    Anesth Analg; 2009 Jan; 108(1):23-9. PubMed ID: 19095826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An examination of the cardiac actions of PD117,302, a κ-opioid receptor agonist.
    Pugsley MK; Saint DA; Hayes ES; Abraham S; Walker MJ
    Eur J Pharmacol; 2015 Aug; 761():330-40. PubMed ID: 26086860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.